Tag: SAE reporting

Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials

Serious vs Non-Serious Adverse Events: When to Report in Clinical Trials

Learn the critical difference between serious and non-serious adverse events in clinical trials-and when each must be reported. Understand the six FDA criteria, avoid common mistakes, and ensure patient safety without overwhelming the system.

RECENT POSTS

June 12, 2025
Lamisil Antifungal Treatment: Guide, Uses, Effectiveness & Tips

Lamisil (terbinafine) is a proven antifungal medication used for athlete's foot, nail fungus, and other stubborn fungal infections. This article cuts through the noise to explain how Lamisil works, when and how to use it, possible side effects, real-world tips, and little-known facts drawn from medical data and everyday experience. If you’re tired of battling with persistent fungal issues or unsure if Lamisil is for you, you'll find actionable advice and honest insights here.

November 23, 2025
Mental Illness and Medication Interactions: Navigating Complex Polypharmacy

Psychiatric polypharmacy-taking multiple mental health medications at once-is common but often unsupported by evidence. Learn why it happens, the risks involved, and how to safely reduce unnecessary drugs without losing stability.

June 12, 2023
Apoaequorin: The Game-Changing Dietary Supplement for Enhanced Memory and Focus

As a blogger, I recently came across a game-changing dietary supplement called Apoaequorin that has been making waves in the health industry. This incredible supplement is known for its potential to enhance memory and focus, which is something we could all benefit from. Derived from the Aequorea Victoria jellyfish, Apoaequorin is a unique protein that has shown promising results in improving cognitive function. I'm excited to explore and share more about this supplement with my readers, as it could be a revolutionary addition to our daily routines. Stay tuned for an in-depth article discussing the benefits, research, and potential side effects of Apoaequorin!

December 3, 2025
Clinical Outcomes After NTI Generic Switches: What Studies Show

Studies show that switching generic versions of narrow therapeutic index (NTI) drugs like warfarin, phenytoin, and cyclosporine can lead to dangerous fluctuations in drug levels. Learn what the evidence says and how to protect yourself.

December 12, 2025
Using Two Patient Identifiers in the Pharmacy for Safety: How It Prevents Medication Errors

Using two patient identifiers in the pharmacy prevents deadly medication errors by ensuring the right person gets the right drug. Learn how barcode systems, documentation, and disciplined verification save lives.